Evaluation of patients’ warfarin knowledge and outcomes following secondary warfarin education (in an outpatient setting) compared with standard inpatient education, as measured by the Oral Anticoagulation Knowledge test.
Not Applicable
Completed
- Conditions
- Cardiovascular - Diseases of the vasculature and circulation including the lymphatic systemAnticoagulation control - Warfarin educationPublic Health - Health promotion/education
- Registration Number
- ACTRN12615000429550
- Lead Sponsor
- Royal Melbourne Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
1. Newly commenced on warfarin (any indication)
2. Inpatient at Royal Melbourne Hospital
3. Age greater than or equal to 18 years old
Exclusion Criteria
1. Duration of warfarin therapy <6 weeks
2. Non English speaking background with no available family translator
3. Prior warfarin therapy
4. Pregnancy
5. Moderate to severe cognitive impairment, defined as an Abbreviated Mental Test Score (AMTS) of 6 or less
6. Discharged to residential or nursing care, as warfarin was unlikely to be self-managed
7. Health professionals with prior knowledge of warfarin
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Oral Anticoagulation Knowledge (OAK) Test, a validated 20 question multiple choice test for assessing patients' knowledge of warfarin. [Administered 6 weeks post discharge from hospital]
- Secondary Outcome Measures
Name Time Method Patients' International Normalised Ratio (INR) control, as measured by Time in Therapeutic Range. [INR data was gathered from the time of discharge up to 2 months post discharge from hospital.]